SQZ Biotechnologies Management
Management criteria checks 2/4
SQZ Biotechnologies' CEO is Howard Bernstein, appointed in Nov 2022, has a tenure of 1.5 years. total yearly compensation is $1.62M, comprised of 24.6% salary and 75.4% bonuses, including company stock and options. directly owns 0.2% of the company’s shares, worth $2.77K. The average tenure of the management team and the board of directors is 2.4 years and 3.6 years respectively.
Key information
Howard Bernstein
Chief executive officer
US$1.6m
Total compensation
| CEO salary percentage | 24.6% |
| CEO tenure | 1.5yrs |
| CEO ownership | 0.2% |
| Management average tenure | 2.4yrs |
| Board average tenure | 3.6yrs |
Recent management updates
Recent updates
SQZ Biotechnologies Company (NYSE:SQZ) Might Not Be As Mispriced As It Looks After Plunging 30%
Jun 26
We Think SQZ Biotechnologies (NYSE:SQZ) Needs To Drive Business Growth Carefully
Jan 05SQZ Biotechnologies GAAP EPS of -$0.77 beats by $0.06, revenue of $3.5M misses by $0.76M
Nov 09SQZ Biotech spikes as H.C. Wainwright initiates with Buy citing platform technology
Oct 20Is SQZ Biotechnologies (NYSE:SQZ) In A Good Position To Deliver On Growth Plans?
Aug 20SQZ Biotechnologies GAAP EPS of -$0.78 misses by $0.01, revenue of $3.22M misses by $0.97M
Aug 04SQZ Biotechnologies names business chief as CFO
Jul 11Time To Worry? Analysts Just Downgraded Their SQZ Biotechnologies Company (NYSE:SQZ) Outlook
May 17Here's Why We're Watching SQZ Biotechnologies' (NYSE:SQZ) Cash Burn Situation
May 02Here's Why We're Watching SQZ Biotechnologies' (NYSE:SQZ) Cash Burn Situation
Jan 11Will SQZ Biotechnologies (NYSE:SQZ) Spend Its Cash Wisely?
Jul 30Need To Know: Analysts Are Much More Bullish On SQZ Biotechnologies Company (NYSE:SQZ)
May 16Newsflash: SQZ Biotechnologies Company (NYSE:SQZ) Analysts Have Been Trimming Their Revenue Forecasts
Mar 25SQZ Biotechnologies Company (NYSE:SQZ) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Mar 20We Think SQZ Biotechnologies (NYSE:SQZ) Can Afford To Drive Business Growth
Feb 01
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2023 | n/a | n/a | -US$72m |
| Jun 30 2023 | n/a | n/a | -US$71m |
| Mar 31 2023 | n/a | n/a | -US$76m |
| Dec 31 2022 | US$2m | US$400k | -US$79m |
| Sep 30 2022 | n/a | n/a | -US$78m |
| Jun 30 2022 | n/a | n/a | -US$78m |
| Mar 31 2022 | n/a | n/a | -US$74m |
| Dec 31 2021 | US$1m | US$391k | -US$69m |
| Sep 30 2021 | n/a | n/a | -US$75m |
| Jun 30 2021 | n/a | n/a | -US$64m |
| Mar 31 2021 | n/a | n/a | -US$55m |
| Dec 31 2020 | US$750k | US$357k | -US$51m |
Compensation vs Market: Howard's total compensation ($USD1.62M) is above average for companies of similar size in the US market ($USD667.63K).
Compensation vs Earnings: Howard's compensation has increased whilst the company is unprofitable.
CEO
Howard Bernstein (66 yo)
1.5yrs
Tenure
US$1,624,513
Compensation
Dr. Howard Bernstein, M.D., Ph D., had been Chief Scientific Officer of SQZ Biotechnologies Company since June 2015 until October 31, 2022. Dr. Bernstein is Director of SQZ Biotechnologies Company since Oc...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Interim CEO & Director | 1.5yrs | US$1.62m | 0.20% $ 2.8k | |
| General Counsel & Secretary | 4.7yrs | US$944.03k | 0.0066% $ 90.1 | |
| Chief Medical Officer | 1.9yrs | US$944.27k | 0% $ 0 | |
| Co-Founder & Member of Scientific Advisory Board | no data | no data | no data | |
| Chief Accounting Officer | 2.5yrs | no data | no data | |
| Chief People Officer | 4yrs | no data | no data | |
| Senior Vice President of CMC & QUALITY | 2.3yrs | no data | no data |
2.4yrs
Average Tenure
61yo
Average Age
Experienced Management: SQZB's management team is considered experienced (2.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Interim CEO & Director | 1.6yrs | US$1.62m | 0.20% $ 2.8k | |
| Co-Founder & Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Director | no data | US$104.40k | 0.74% $ 10.2k | |
| Independent Director | 2.8yrs | US$96.62k | 0% $ 0 | |
| Independent Director | 11.2yrs | US$89.40k | 1.15% $ 15.8k | |
| Independent Chairman | 2.8yrs | US$94.40k | 0% $ 0 | |
| Independent Director | 6yrs | US$86.90k | 0% $ 0 | |
| Independent Director | 5.8yrs | US$94.40k | 0% $ 0 | |
| Independent Director | 3.6yrs | US$94.40k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | no data | no data |
3.6yrs
Average Tenure
61yo
Average Age
Experienced Board: SQZB's board of directors are considered experienced (3.6 years average tenure).